- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging treatments for wet age-related macular degeneration
Authors
Keywords
-
Journal
EXPERT OPINION ON EMERGING DRUGS
Volume 19, Issue 1, Pages 157-164
Publisher
Informa Healthcare
Online
2014-02-21
DOI
10.1517/14728214.2014.884559
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combination therapy for the treatment of neovascular age-related macular degeneration
- (2013) Miriam Englander et al. CURRENT OPINION IN OPHTHALMOLOGY
- Stereotactic Radiotherapy for Neovascular Age-related Macular Degeneration
- (2013) Timothy L. Jackson et al. OPHTHALMOLOGY
- Current Anti–Vascular Endothelial Growth Factor Dosing Regimens
- (2013) Julia A. Haller OPHTHALMOLOGY
- Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
- (2012) Nicholas Papadopoulos et al. ANGIOGENESIS
- Balancing risk in ophthalmic prescribing: assessing the safety of anti-VEGF therapies and the risks associated with unlicensed medicines
- (2012) Peter K. Kaiser et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Wet AMD market
- (2012) Basharut A. Syed et al. NATURE REVIEWS DRUG DISCOVERY
- Safety of Submacular Suprachoroidal Drug Administration via a Microcatheter: Retrospective Analysis of European Treatment Results
- (2012) Manfred Tetz et al. OPHTHALMOLOGICA
- Neovascular Age-Related Macular Degeneration
- (2012) Daniele Veritti et al. OPHTHALMOLOGICA
- Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
- (2012) Daniel F. Martin et al. OPHTHALMOLOGY
- Macular Epiretinal Brachytherapy in Treated Age-related Macular Degeneration (MERITAGE)
- (2012) Robert Petrarca et al. OPHTHALMOLOGY
- Epimacular Brachytherapy for Neovascular Age-related Macular Degeneration
- (2012) Pravin U. Dugel et al. OPHTHALMOLOGY
- Bevacizumab for Neovascular Age-Related Macular Degeneration Using a Treat-and-Extend Regimen: Clinical and Economic Impact
- (2011) Gary Shienbaum et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Cytokines in neovascular age-related macular degeneration: fundamentals of targeted combination therapy
- (2011) J. R. de Oliveira Dias et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- sFLT01: A Novel Fusion Protein with Antiangiogenic Activity
- (2011) R. G. Bagley et al. MOLECULAR CANCER THERAPEUTICS
- Drug delivery to the posterior segment of the eye
- (2010) Thilini Rasika Thrimawithana et al. DRUG DISCOVERY TODAY
- Current and future therapies for age-related macular degeneration
- (2009) Julia Beutel et al. EXPERT OPINION ON EMERGING DRUGS
- Emerging Pharmacologic Therapies for Wet Age-Related Macular Degeneration
- (2009) Zhang Ni et al. OPHTHALMOLOGICA
- Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial
- (2008) L J Singerman et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study
- (2008) David M. Brown et al. OPHTHALMOLOGY
- The Pharmacology Study of a New Recombinant Human VEGF Receptor-Fc Fusion Protein on Experimental Choroidal Neovascularization
- (2008) Ming Zhang et al. PHARMACEUTICAL RESEARCH
- The Natural History and Prognosis of Neovascular Age-Related Macular Degeneration
- (2007) Tien Wong et al. OPHTHALMOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search